EnteroMedics Inc. (ETRM) Enters Overbought Territory
Biotech columnist Adam Feuerstein answers readers' questions about health care companies.
One is a buy and for the other you should wait.
EnteroMedics Inc. was a big mover last session, as the company saw its shares rise by nearly 64% on the day.
ST. PAUL, MN -- (Marketwired) -- 12/03/13 -- EnteroMedics Inc. (NASDAQ: ETRM), the developer of medical devices using neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal ...